World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
25126
World Ranking
17953
National Ranking
752

Anthony Fyles publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anthony Fyles sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 445 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anthony Fyles D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony Fyles sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Anthony Fyles is affiliated with the Princess Margaret Cancer Centre in Canada. Their research focuses primarily on cancer treatment, particularly involving gynecologic and breast cancers, with extensive work in oncology and radiotherapy.

Fyles's main fields of study include Medicine and Biochemistry, Genetics and Molecular Biology. Within these broad areas, they have contributed to subfields such as Obstetrics and Gynecology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Oncology, and Pathology and Forensic Medicine.

The scientist's main research topics encompass:

  • Endometrial and Cervical Cancer Treatments
  • Breast Cancer Treatment Studies
  • Cervical Cancer and HPV Research
  • Ovarian cancer diagnosis and treatment
  • Breast Lesions and Carcinomas
  • Advances in Oncology and Radiotherapy
  • Cancer Genomics and Diagnostics

Among notable recent papers authored by colleagues in the field and aligned with Fyles's research interests are:

  • Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy, 2020, Journal of Clinical Oncology
  • Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial, 2023, The Lancet Oncology
  • Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer, 2023, New England Journal of Medicine
  • NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update, 2020, International Journal of Radiation Oncology*Biology*Physics
  • Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry, 2023, British Journal of Cancer

Frequent coauthors collaborating with Fyles include:

  • Jennifer Croke
  • Kathy Han
  • Michael Milosevic
  • Fei-Fei Liu
  • Linda Mileshkin

The scientist has contributed multiple publications to a range of academic venues, with the most frequent being:

  • Radiotherapy and Oncology
  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Cancer Research
  • Advances in Radiation Oncology

Best Publications

  • Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

    Timothy J Whelan;Jean-Philippe Pignol;Mark N Levine;Jim A Julian

  • Oxygenation predicts radiation response and survival in patients with cervix cancer

    Anthony W Fyles;Anthony W Fyles;Michael Milosevic;Michael Milosevic;Raimond Wong;Raimond Wong;Mary-Claire Kavanagh

  • Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.

    Anthony W. Fyles;David R. McCready;Lee A. Manchul;Maureen E. Trudeau

  • Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer

    Timothy Whelan;Robert MacKenzie;Jim Julian;Mark Levine

  • Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

    Ignace Vergote;Jos De Brabanter;Anthony Fyles;Kamma Bertelsen

  • Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

    Jeffrey M. Arbeit;J. Martin Brown;K. S.Clifford Chao;J. Donald Chapman

  • Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    Stephanie M. de Boer;Melanie E. Powell;Linda Mileshkin;Dionyssios Katsaros

  • Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States

    Kathy Han;Michael Milosevic;Anthony Fyles;Melania Pintilie

  • Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

    Alicia León-Castillo;Stephanie M. de Boer;Melanie E. Powell;Linda R. Mileshkin

  • Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer

    A. Fyles;M. Milosevic;D. Hedley;M. Pintilie

  • Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer

    Karen Lim;William Small;Lorraine Portelance;Carien Creutzberg

  • The Effect of Treatment Duration in the Local Control of Cervix Cancer

    Anthony Fyles;Thomas J. Keane;Michael Barton;Janis Simm

  • Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    Stephanie M de Boer;Melanie E Powell;Linda Mileshkin;Dionyssios Katsaros

  • Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy

    Ivo A. Olivotto;Timothy J. Whelan;Sameer Parpia;Do-Hoon Kim

  • External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.

    Timothy J Whelan;Jim A Julian;Tanya S Berrang;Do-Hoon Kim

  • Interstitial Fluid Pressure Predicts Survival in Patients with Cervix Cancer Independent of Clinical Prognostic Factors and Tumor Oxygen Measurements

    Michael Milosevic;Anthony Fyles;David Hedley;Melania Pintilie

  • Diffusion-weighted MRI in cervical cancer

    Patrick Z. McVeigh;Aejaz M. Syed;Michael Milosevic;Anthony Fyles

  • MicroRNA-301 mediates proliferation and invasion in human breast cancer.

    Wei Shi;Kate Gerster;Nehad M. Alajez;Jasmine Tsang

  • Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer–a Meta-analysis

    H. Lukka;H. Hirte;A. Fyles;G. Thomas

  • Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study.

    Philip Chan;Robert Dinniwell;Robert Dinniwell;Masoom A. Haider;Masoom A. Haider;Young Bin Cho;Young Bin Cho

Frequent Co-Authors

Michael Milosevic
Michael Milosevic Princess Margaret Cancer Centre
Melania Pintilie
Melania Pintilie Princess Margaret Cancer Centre
Richard P. Hill
Richard P. Hill Princess Margaret Cancer Centre
Fei-Fei Liu
Fei-Fei Liu Princess Margaret Cancer Centre
David A. Jaffray
David A. Jaffray The University of Texas MD Anderson Cancer Center
David W. Hedley
David W. Hedley Princess Margaret Cancer Centre
Carien L. Creutzberg
Carien L. Creutzberg Leiden University Medical Center
Amit M. Oza
Amit M. Oza Princess Margaret Cancer Centre
Timothy J. Whelan
Timothy J. Whelan McMaster University
Hans W. Nijman
Hans W. Nijman University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and related healthcare pathways can offer flexibility for those interested in the medical field but looking for less traditional routes. For example, pursuing a career in medical billing and coding can be a great entry into healthcare administration. Many medical billing and coding schools that accept fafsa provide online options, making education more accessible and financially manageable.

If nursing interests you, there are do you have to take the teas test to get into nursing school programs available that do not require the TEAS or HESI exams for admission, streamlining the application process for prospective students.

For those aiming at leadership roles, enrolling in a health administration degree online offers the chance to step into management within healthcare systems. Additionally, registered nurses wanting to advance their practice can explore adn to np bridge programs, providing a direct path from an ADN to a nurse practitioner qualification.

These alternative degrees and pathways expand access to promising medical careers, whether your interest lies in patient care, administration, or specialized support roles.

Best Scientists Citing Anthony Fyles

Trending Scientists